Literature DB >> 15039185

Triple-phase dynamic MRI of intratumoral vessel density and hyalinization grade in uterine leiomyomas.

Ken Shimada1, Isamu Ohashi, Ichiro Kasahara, Naoyuki Miyasaka, Hitoshi Shibuya.   

Abstract

OBJECTIVE: Our purpose was to clarify the relationship between the tissue vascularity shown on triple-phase dynamic MRI and the number of intratumoral vessels and degree of hyalinization, which are two histopathologic changes in leiomyoma. SUBJECTS AND METHODS. The subjects were 10 premenopausal patients with 20 leiomyomas who had undergone surgery without preoperative gonadotropin-releasing hormone analogue treatment. Intratumoral vessel density was determined by the mean number of intratumoral vessels with at least one smooth-muscle layer in the optic fields magnified 100 times. Hyalinization grade was determined by the severity of hyalinization, histopathologically classified in three grades. The enhancement index (EI) of the leiomyoma was calculated using the formula EI(t) = [S(t) - S(0)] / S(0), where S(0) is the signal intensity on pre-enhanced T1-weighted images and S(t) is the signal intensity on each dynamic phase image (t = 20, 60, and 180 sec) [corrected]. The histopathologic parameters of intratumoral vessel density and hyalinization grade were compared with the enhancement indexes obtained from the triple-phase dynamic MRI.
RESULTS: We found positive correlations between intratumoral vessel density and EI(60) and between intratumoral vessel density and EI(180) (in both cases, p = 0.0028 and r = 0.69). We found significant differences among the mean enhancement indexes for each hyalinization grade at all dynamic phases (p < 0.01). The leiomyomas with lower intratumoral vessel densities tended to show greater hyalinization.
CONCLUSION: Our results showed that leiomyomas with only slight hyalinization or with abundant vessels were well enhanced, but the leiomyomas with severe hyalinization enhanced poorly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039185     DOI: 10.2214/ajr.182.4.1821043

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

1.  Dynamic contrast-enhanced MRI serves as a predictor of HIFU treatment outcome for uterine fibroids with hyperintensity in T2-weighted images.

Authors:  Wen-Peng Zhao; Jin-Yun Chen; Wen-Zhi Chen
Journal:  Exp Ther Med       Date:  2015-11-18       Impact factor: 2.447

2.  Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient.

Authors:  Irina K Dimitrova; Jennifer K Richer; Michael C Rudolph; Nicole S Spoelstra; Elaine M Reno; Theresa M Medina; Andrew P Bradford
Journal:  Fertil Steril       Date:  2008-07-30       Impact factor: 7.329

3.  Growth of uterine leiomyomata among premenopausal black and white women.

Authors:  Shyamal D Peddada; Shannon K Laughlin; Kelly Miner; Jean-Philippe Guyon; Karen Haneke; Heather L Vahdat; Richard C Semelka; Ania Kowalik; Diane Armao; Barbara Davis; Donna Day Baird
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-01       Impact factor: 11.205

4.  Quantitative serial MRI of the treated fibroid uterus.

Authors:  Kirsty I Munro; Michael J Thrippleton; Alistair R W Williams; Graham McKillop; Jane Walker; Andrew W Horne; David E Newby; Richard A Anderson; Scott I Semple; Ian Marshall; Steff C Lewis; Robert P Millar; Mark E Bastin; Hilary O D Critchley
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

5.  Spontaneous complete regression of large uterine fibroid after the second vaginal delivery: Case report.

Authors:  Myounghwan Kim
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

Review 6.  New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions.

Authors:  Pamela Causa Andrieu; Sungmin Woo; Tae-Hyung Kim; Elizabeth Kertowidjojo; Anjelica Hodgson; Simon Sun
Journal:  Curr Opin Oncol       Date:  2021-09-01       Impact factor: 3.915

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.